Venture Capital

New research shows high food prices are forcing U.S. consumers to cut beef, produce, and dairy, trading nutrition for affordability at the grocery aisle.

A new alliance between CollegeVine and Human Capital Education aims to solve AI's biggest campus challenge: turning powerful tech into real-world results.

Private firm ION Minerals now controls 280,000 acres across Texas and Canada, a bold move to dominate the future EV battery supply chain.

Exodigo's AI tech, now available to Texas agencies, promises to end costly underground surprises in public works, making projects safer and cheaper.

A startup's cooling tech, inspired by nuclear reactors, offers a 15% compute boost with zero water use, tackling the AI industry's energy crisis.

Interlink Electronics reports a wider Q4 loss but makes key moves in autonomous vehicle and robotic surgery sensors, signaling a major strategic pivot.

Austin startup Scalvy has secured major Series A funding to deploy its radical new power delivery platform for AI data centers and the energy grid.

A new partnership will embed real-world cell therapy manufacturing into NJIT's graduate program, aiming to fill a critical skills gap in the biotech industry.

The nation's top aesthetic clinic partners with BENEV to exclusively debut XTherma®, the first RF and cryogen device for pain-free skin rejuvenation.

After a $4.15B exit, Adam Wexler is back in music with The Hidden Jams, a non-profit aiming to replace algorithms with human-powered discovery.

As youth sports costs skyrocket, Winmark's Play It Again Sports enlists new pro athletes to champion its resale model and make sports accessible for all.

With a $2B war chest and a key simulation acquisition, Shield AI is accelerating the race to deploy AI pilots, reshaping the future of global defense.

Healthcare powerhouse Terri Cooper joins Morphic Medical's board, a strategic move to navigate clinical trials for its non-surgical RESET diabetes therapy.

Indian VLSI firm Ambit Semiconductors expands to Austin, Texas, aiming to bridge global talent and capture the future of AI and automotive chip design.

Freedom Trail Capital joins Kapor Capital and the NBA, revealing a new investment model where authentic influence is the ultimate unfair advantage.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

A new partnership between Boehringer Ingelheim and the CT Science Center seeks to build a talent pipeline for the state's booming biopharma industry.

As AI pushes Canada's grid to the brink, a firm pivots from steel to hydrogen, joining an alliance to solve the data centre energy crisis.

Armata Pharmaceuticals posts a staggering $174M annual loss, triggering a 'going concern' alert, yet its promising phage therapy pipeline advances.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.